UNITED THERAPEUTICS Corp — Director's Dealing 2021

Dec 2, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: UNITED THERAPEUTICS Corp (UTHR)
CIK: 0001082554
Period of Report: 2021-12-02

Reporting Person: MAHON PAUL A (EVP & General Counsel)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-12-02	Common Stock	M	6000	$111.00	Acquired	42369	Direct
2021-12-02	Common Stock	S	1100	$187.4841	Disposed	41269	Direct
2021-12-02	Common Stock	S	1262	$188.979	Disposed	40007	Direct
2021-12-02	Common Stock	S	2764	$189.8191	Disposed	37243	Direct
2021-12-02	Common Stock	S	874	$190.7965	Disposed	36369	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-12-02	Stock Options	$111.00	M	6000	Disposed	2028-03-15	Common Stock (6000)	Direct

Footnotes

F1: This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person.

F2: This transaction was executed in multiple trades at prices ranging from $187.19 to $187.86. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F3: This transaction was executed in multiple trades at prices ranging from $188.48 to $189.47. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F4: This transaction was executed in multiple trades at prices ranging from $189.48 to $190.40. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F5: This transaction was executed in multiple trades at prices ranging from $190.49 to $191.025. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.